How To Detect Liver Cancer Early

If you are suffering from chronic hepatitis B and start experiencing symptoms such as upper right abdominal pain or jaundice, it could be a sign of liver cancer. In such cases, it is crucial to consider the possibility of hepatocellular carcinoma and take prompt diagnostic steps. One of the most effective and accessible ways to screen for liver cancer is through a liver ultrasound. It is highly recommended that individuals with chronic hepatitis B undergo a liver and bile duct ultrasound every six months, along with blood tests for tumor markers.

Ultrasound imaging can often detect changes in liver tissue density. If a mass or low-density area is identified in the liver, further diagnostic evaluation is necessary. While ultrasound is a valuable initial screening tool, more advanced imaging techniques such as contrast-enhanced CT scans or MRI are essential to determine the exact size, location, and number of tumors. These tests also help identify whether the cancer is solitary or multifocal, if there is any vascular invasion such as cancer thrombus, and whether the tumor is primary liver cancer, metastatic cancer, or cholangiocarcinoma.

In addition to imaging, blood tests for tumor markers like AFP (alpha-fetoprotein) play a significant role in liver cancer diagnosis. Some patients may show elevated tumor markers without clear imaging abnormalities. In such cases, a hepatic angiogram may be required to confirm the presence of a tumor. Combining radiological and blood testing methods significantly improves diagnostic accuracy.

Early detection through regular screening is key to improving outcomes for liver cancer patients. Those with chronic hepatitis B should maintain a consistent monitoring schedule with their healthcare provider. This proactive approach can lead to earlier diagnosis and more effective treatment options.